Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 31, 1997

Study Completion Date

March 31, 2009

Conditions
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Interventions
DRUG

fluorouracil

Trial Locations (62)

1

Christchurch Hospital, Christchurch

7925

Groote Schuur Hospital, Cape Town, Cape Town

90035--003

Porto Alegre Hospital, Porto Alegre

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

M5G 1X5

Mount Sinai Hospital - Toronto, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

H3T 1C5

Hopital Sainte Justine, Montreal

FIN-0-0180

Maria Hospital, Helsinki

1066 CX

Antoni van Leeuwenhoekhuis, Amsterdam

N-0310

Norwegian Radium Hospital, Oslo

BA1 3NG

Royal United Hospital, Bath

B15 2TT

University Birmingham, Birmingham

B16 8ET

Children's Hospital - Birmingham UK, Birmingham

BD9 6RJ

Bradford Hospitals NHS Trust, Bradford

BN2 5BE

Royal Sussex County Hospital, Brighton

BS2 8BJ

Bristol Royal Hospital for Sick Children, Bristol

BS2 8ED

Bristol Oncology Centre, Bristol

CB2 2QQ

Addenbrooke's NHS Trust, Cambridge

CT2 7NR

Kent and Canterbury Hospital, Canterbury

CV2 2DX

Walsgrave Hospital, Coventry

DE1 2QY

Derbyshire Royal Infirmary, Derby

DE1 3BA

Derbyshire Children's Hospital, Derby

EX2 5DW

Royal Devon and Exeter Hospital, Exeter

GL1 3NN

Gloucester Royal NHS Trust - Glouchester Royal Hospital, Gloucester

GU2 5XX

Royal Surrey County Hospital, Guildford

NW3 2QG

Royal Free Hospital, Hampstead, London

HD3 3EA

Huddersfield Royal Infirmary, Huddersfield, West Yorks

LS16 6QB

Cookridge Hospital, Leeds

LS9 7TF

St. James's Hospital, Leeds

LE1 5WW

University Hospitals of Leicester, Leicester

EC1A 7BE

St. Bartholomew's Hospital, London

SE1 7EH

Guy's, King's and St. Thomas' Hospitals Trust, London

SW1P 2AP

Westminster Hospital, London

W1N 8AA

Middlesex Hospital- Meyerstein Institute, London

WC1E 6AU

University College Hospital, London

M27 SHA

Manchester Children's Hospitals (NHS Trust), Manchester

L63 4JY

Clatterbridge Centre for Oncology NHS Trust, Merseyside

TS4 3BW

South Tees Acute Hospitals NHS Trust, Middlesbrough, Cleveland

NE1 4LP

Royal Victoria Infirmary, Newcastle upon Tyne

NE4 6BE

Newcastle General Hospital, Newcastle upon Tyne

HA6 2RN

Mount Vernon Hospital, Northwood

NR1 3SR

Norfolk & Norwich Hospital, Norwich

0X3 7LJ

Oxford Radcliffe Hospital, Oxford

P03 6AD

Portsmouth Hospitals NHS Trust, Portsmouth

S10 2TH

Children's Hospital - Sheffield, Sheffield

S1O 2SJ

Weston Park Hospital, Sheffield

SO14 0YG

Royal South Hants Hospital, Southampton

SO16 6YD

Southampton General Hospital, Southampton

SM2 5PT

Royal Marsden Hospital, Sutton

TF6 6TF

Princess Royal Hospital, Telford

WS2 9PS

Walsall Manor Hospital, Walsall

Unknown

Southend General Hospital, Westcliff-on-Sea

Royal Hospital for Sick Children, Edinburgh

Ysbyty Gwynedd, Bangor

BT12 6BE

Royal Belfast Hospital for Sick Children, Belfast

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

DD1 9SY

Ninewells Hospital and Medical School, Dundee

EH4 9NQ

Western General Hospital, Edinburgh

G11 6NT

Beatson Oncology Centre, Glasgow

G4 0SF

Royal Infirmary, Glasgow

CF6 1XX

Llandough Hospital, Penarth

PR2 9HT

Royal Preston Hospital, Preston

Sponsors
All Listed Sponsors
lead

Medical Research Council

OTHER_GOV

NCT00003175 - Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer | Biotech Hunter | Biotech Hunter